A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/17 (2006.01) A61K 31/40 (2006.01) A61K 31/421 (2006.01) A61K 31/426 (2006.01) A61K 31/4436 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/4725 (2006.01) A61K 31/496 (2006.01) A61K 31/497 (2006.01) A61K 31/5377 (2006.01) A61K 31/54 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 27/02 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2475703
This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
La présente invention a trait à des procédés d'utilisation pour le traitement de maladies causées par la voie de transduction de signal induit par le facteur de croissance endothéliale caractérisée par des processus d'angiogenèse anormale ou d'hyperpermeabilité.
Dumas Jacques
Elting James
Hatoum-Makdad Holia
Scott William J.
Bayer Pharmaceuticals Corporation
Smart & Biggar
LandOfFree
Aryl ureas with angiogenesis inhibiting activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl ureas with angiogenesis inhibiting activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ureas with angiogenesis inhibiting activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1930930